<HTML>
 <HEAD>
 <!-- $MVD$:app("MicroVision WebExpress") -->
 <TITLE>4168i04</TITLE><!-- $MVD$:template("","0","0") -->
 <!-- $MVD$:fontset("Symbol","Symbol") -->
 <META NAME="GENERATOR" CONTENT="MicroVision Development / WebExpress">
 </HEAD>
 <BODY BGCOLOR=#FFFFFF>
 <P ALIGN=CENTER>
 <CENTER><img src="http:/img/fbpe/bjmbr/v34n11/4168i04.gif" ALIGN=BOTTOM BORDER=0 VSPACE=0 HSPACE=0></CENTER>
 </P><P>
 Figure 4. <I>A</I>, <I>B</I>, Scatter plots of the relationship between the best-estimated AUC<SUB>0-</SUB><!-- $MVD$:face("Symbol") --><FONT FACE="Symbol"><SUB>&#165;</SUB></FONT> (&#181;g h<BR>
 ml<SUP>-1</SUP>) or C<SUB>max</SUB> (&#181;g/ml) of MAA (abscissa) and the corresponding parameter values derived from the 3-point limited-sampling strategy (LSS) models (see equations in Table 5) for each volunteer (ordinate), using the jack-knife approach (Methods). The continuous line in each plot represents the line of identity between the LSS-derived and the best-estimated AUC<SUB>0-</SUB><!-- $MVD$:face("Symbol") --><FONT FACE="Symbol"><SUB>&#165;</SUB></FONT><SUB> </SUB>(A) or C<SUB>max</SUB> (B). AUC<SUB>0-</SUB><!-- $MVD$:face("Symbol") --><FONT FACE="Symbol"><SUB>&#165;</SUB></FONT><SUB> </SUB>= area under the plasma drug concentration versus time curve from 0 to infinity; C<SUB>max </SUB>= peak plasma concentration.</BODY>
</HTML>